ไอซ์แลนด์ -
ไอซ์แลนด์ -
LYFJASTOFNUN (Icelandic Medicines Agency)
medilax mixtúra, lausn 667 mg/ml
viatris aps - lactulosum inn - mixtúra, lausn - 667 mg/ml
ไอซ์แลนด์ -
ไอซ์แลนด์ -
LYFJASTOFNUN (Icelandic Medicines Agency)
norgesic 35 mg/450 mg tafla 35+450 mg
viatris aps - orphenadrinum cítrat; paracetamolum inn - tafla - 35+450 mg
ไอซ์แลนด์ -
ไอซ์แลนด์ -
LYFJASTOFNUN (Icelandic Medicines Agency)
tambocor tafla 100 mg
viatris aps - flecainidum acetat - tafla - 100 mg
ไอซ์แลนด์ -
ไอซ์แลนด์ -
LYFJASTOFNUN (Icelandic Medicines Agency)
tibinide tafla 300 mg
viatris aps - isoniazidum inn - tafla - 300 mg
ไอซ์แลนด์ -
ไอซ์แลนด์ -
LYFJASTOFNUN (Icelandic Medicines Agency)
treo freyðitafla 50 mg/ 500 mg
viatris aps - coffeinum; acidum acetylsalicylicum - freyðitafla - 50 mg/ 500 mg
ไอซ์แลนด์ -
ไอซ์แลนด์ -
LYFJASTOFNUN (Icelandic Medicines Agency)
treo hindbær freyðitafla 500/50 mg
viatris aps - coffeinum; acidum acetylsalicylicum - freyðitafla - 500/50 mg
ไอซ์แลนด์ -
ไอซ์แลนด์ -
LYFJASTOFNUN (Icelandic Medicines Agency)
mucomyst freyðitafla 200 mg
viatris aps - acetylcysteinum inn - freyðitafla - 200 mg
ไอซ์แลนด์ -
ไอซ์แลนด์ -
LYFJASTOFNUN (Icelandic Medicines Agency)
treo freyðitafla 500 mg/50 mg
viatris aps - acidum acetylsalicylicum; coffeinum - freyðitafla - 500 mg/50 mg
สหภาพยุโรป -
ไอซ์แลนด์ -
EMA (European Medicines Agency)
dimethyl fumarate mylan
mylan ireland limited - dímetýl fúmarat - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi lyf - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
สหภาพยุโรป -
ไอซ์แลนด์ -
EMA (European Medicines Agency)
amlodipine / valsartan mylan
mylan pharmaceuticals limited - meðferð besilate, valsartan - háþrýstingur - lyf sem hafa áhrif á renín-angíótensín kerfið - meðferð við nauðsynlegum háþrýstingi. meðferð/valsartan mylan er ætlað í fullorðnir sem blóðþrýstingur er ekki nægilega stjórn á meðferð eða valsartan sér.